GeneDx Holdings Corp. Cash and Cash Equivalents
GeneDx Holdings Corp. (WGS) had Cash and Cash Equivalents of $60.32 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-03
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $60.32M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $93.92M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $105.00M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $95.97M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $60.32M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $93.92M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $105.00M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $95.97M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $74.12M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $99.70M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $85.21M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $57.89M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $56.08M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $83.67M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $99.68M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $87.39M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $156.66M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $201.90M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $123.93M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $191.36M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $284.65M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $315.00M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $400.57M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $461.28M 10-K · filed 2022-03-14 | |
| 2021-06-30 | $26.50M 10-K · filed 2022-03-14 | $167.96K 10-Q · filed 2021-07-21 |
| 2021-03-31 | $58.65M 10-K · filed 2022-03-14 | $627.41K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $108.13M 10-K · filed 2023-03-16 | $1.09M 10-K · filed 2021-03-30 |
| 2020-09-30 | $1.14M 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |